130 studies found for:    Open Studies | "Neuroblastoma"
Show Display Options
Rank Status Study
21 Unknown  Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
Condition: Neuroblastoma
Interventions: Genetic: gene mapping;   Genetic: polymorphism analysis
22 Unknown  Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody Ch14.18;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: isotretinoin;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
23 Available 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG);   Drug: 131 I-MIBG
24 Recruiting A Pilot Study on ALK Gene Mutations in Neuroblastoma
Condition: Neuroblastoma
Intervention:
25 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
26 Recruiting A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in Children and Adolescents With Recurrent/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: Humanized anti-GD2 antibody;   Drug: Chemotherapy;   Other: Cytokines;   Biological: Natural killer cells
27 Unknown  Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation
Condition: Neuroblastoma
Intervention: Procedure: Reduced-intensity allogeneic hematopoietic stem cell transplantation
28 Recruiting 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
Condition: Neuroblastoma
Intervention: Genetic: iC9-GD2 T Cell Lymphocytes
29 Recruiting Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
Conditions: Neuroblastoma;   Bone Marrow, Sympathetic Nervous System
Intervention: Drug: cyclophosphamide, vincristine, topotecan ,allogeneic NK cells & 3F8
30 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
31 Unknown  Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: tandem high-dose chemotherapy
32 Recruiting High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)
33 Not yet recruiting Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Busulfan - Fludarabine - TBI
34 Unknown  131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
35 Unknown  Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty
Condition: Neuroblastoma
Intervention:
36 Recruiting N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Bevacizumab;   Drug: cyclophosphamide;   Drug: zoledronic acid
37 Recruiting N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: fenretinide lipid matrix;   Drug: ketoconazole;   Other: laboratory biomarker analysis;   Other: pharmacological study
38 Recruiting Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Zoledronic Acid;   Biological: Aldesleukin
39 Not yet recruiting Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Conditions: Neuroblastoma;   Neoplasm, Residual;   Effects of Immunotherapy
Intervention: Drug: Dinutuximab. Immunotherapy
40 Unknown  131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol
Condition: Neuroblastoma
Intervention: Drug: Metaiodobenzylguanidine (MIBG)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years